长期大麻使用者的转运蛋白PET成像研究
这项横断面研究在加拿大多伦多招募24名长期大麻使用者和27名非使用者对照,采用[18F]FEPPA PET测量脑内18-kDa转运蛋白(TSPO)总分布容积。结果显示大麻使用者TSPO水平较对照高23.3%,合并大麻使用障碍者高31.5%,且脑内TSPO水平与应激焦虑及循环C反应蛋白相关。
要点
- 长期大麻使用者脑内TSPO总分布容积较非使用者高23.3%(Cohen d=0.6)。
- 合并大麻使用障碍亚组TSPO水平较对照高31.5%(Cohen d=0.8)。
- 大麻使用者脑内TSPO水平与应激焦虑及循环C反应蛋白水平相关。
核心结论
- 长期大麻使用者脑内TSPO水平高于非使用者,合并大麻使用障碍者更明显。
研究设计与样本
- 所有参与者接受[18F]FEPPA PET扫描,量化感兴趣区TSPO总分布容积。
- 同时测量应激焦虑及外周炎症细胞因子和C反应蛋白水平。
主要发现
- 大麻使用者较对照TSPO总分布容积更高(主效应F1,48=6.5,P=.01;ROI效应F1,200=28.4,P<.001;Cohen d=0.6;高23.3%)。
- 大麻使用障碍亚组(n=15)较对照TSPO更高(主效应F1,39=8.5,P=.006;ROI效应F1,164=19.3,P<.001;Cohen d=0.8;高31.5%)。
- 大麻使用者脑内较高TSPO水平与应激焦虑及较高循环C反应蛋白水平相关。
关键数值与推荐
- 大麻使用者入组条件为尿药筛查仅大麻阳性且过去12个月每周至少使用4次大麻和/或符合大麻使用障碍标准。
临床怎么用
- 提示长期大麻使用可能与脑内神经免疫激活标志物TSPO升高相关,合并大麻使用障碍者更需关注。
- 脑内TSPO水平与应激焦虑及外周C反应蛋白的关联提示可将神经免疫与行为及炎症指标结合评估。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cannabis is the most commonly used illicit drug in the world. Cannabinoids have been shown to modulate immune responses; however, the association of cannabis with neuroimmune function has never been investigated in vivo in the human brain. OBJECTIVE: To investigate neuroimmune activation or 18-kDa translocator protein (TSPO) levels in long-term cannabis users, and to evaluate the association of brain TSPO levels with behavioral measures and inflammatory blood biomarkers. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study based in Toronto, Ontario, recruited individuals from January 1, 2015, to October 30, 2018. Participants included long-term cannabis users (n = 24) and non-cannabis-using controls (n = 27). Cannabis users were included if they had a positive urine drug screen for only cannabis and if they used cannabis at least 4 times per week for the past 12 months and/or met the criteria for cannabis use disorder. All participants underwent a positron emission tomography scan with [18F]FEPPA, or fluorine F 18-labeled N-(2-(2-fluoroethoxy)benzyl)-N-(4-phenoxypyridin-3-yl)acetamide. MAIN OUTCOMES AND MEASURES: Total distribution volume was quantified across regions of interest. Stress and anxiety as well as peripheral measures of inflammatory cytokines and C-reactive protein levels were also measured. RESULTS: In total, 24 long-term cannabis users (mean [SD] age, 23.1 [3.8] years; 15 men [63%]) and 27 non-cannabis-using controls (mean [SD] age, 23.6 [4.2] years; 18 women [67%]) were included and completed all study procedures. Compared with the controls, cannabis users had higher [18F]FEPPA total distribution volume (main group effect: F1,48 = 6.5 [P = .01]; ROI effect: F1,200 = 28.4 [P < .001]; Cohen d = 0.6; 23.3% higher), with a more prominent implication for the cannabis use disorder subgroup (n = 15; main group effect: F1,39 = 8.5 [P = .006]; ROI effect: F1,164 = 19.3 [P < .001]; Cohen d = 0.8; 31.5% higher). Greater TSPO levels in the brain were associated with stress and anxiety and with higher circulating C-reactive protein levels in cannabis users. CONCLUSIONS AND RELEVANCE: The results of this study suggest that TSPO levels in cannabis users, particularly in those with cannabis use disorder, are higher than those in non-cannabis-using controls. The findings emphasize the need for more complementary preclinical systems for a better understanding of the role of cannabinoids and TSPO in neuroimmune signaling.
引用
- Da Silva T, Hafizi S, Watts JJ, et al. In Vivo Imaging of Translocator Protein in Long-term Cannabis Users. JAMA Psychiatry. 2019. PMID: 31532458. doi:10.1001/jamapsychiatry.2019.2516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。